Isabel Elizondo López de Landache, Leire Braceras Izaguirre
{"title":"通过使用活性物质哌醋甲酯确定巴斯克地区自治社区注意缺陷多动障碍的患病率","authors":"Isabel Elizondo López de Landache, Leire Braceras Izaguirre","doi":"10.1016/j.gmb.2011.11.005","DOIUrl":null,"url":null,"abstract":"<div><p>Attention deficit disorder with hyperactivity (ADDH) is a common behavioral disorder in childhood. The main drug for treatment is methylphenidate. We identified the prevalence of ADDH by determining the use of this drug in our environment.</p><p>There are few data on the prevalence of ADDH in the literature, but our data are in line with the ranges cited in various articles.</p></div>","PeriodicalId":35686,"journal":{"name":"Gaceta Medica de Bilbao","volume":"109 2","pages":"Pages 49-51"},"PeriodicalIF":0.0000,"publicationDate":"2012-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmb.2011.11.005","citationCount":"0","resultStr":"{\"title\":\"Determinación de la prevalencia del trastorno por déficit de atención con hiperactividad en la comunidad autónoma del País Vasco a través del consumo del principio activo metilfenidato\",\"authors\":\"Isabel Elizondo López de Landache, Leire Braceras Izaguirre\",\"doi\":\"10.1016/j.gmb.2011.11.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Attention deficit disorder with hyperactivity (ADDH) is a common behavioral disorder in childhood. The main drug for treatment is methylphenidate. We identified the prevalence of ADDH by determining the use of this drug in our environment.</p><p>There are few data on the prevalence of ADDH in the literature, but our data are in line with the ranges cited in various articles.</p></div>\",\"PeriodicalId\":35686,\"journal\":{\"name\":\"Gaceta Medica de Bilbao\",\"volume\":\"109 2\",\"pages\":\"Pages 49-51\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.gmb.2011.11.005\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gaceta Medica de Bilbao\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0304485811001399\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gaceta Medica de Bilbao","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304485811001399","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Determinación de la prevalencia del trastorno por déficit de atención con hiperactividad en la comunidad autónoma del País Vasco a través del consumo del principio activo metilfenidato
Attention deficit disorder with hyperactivity (ADDH) is a common behavioral disorder in childhood. The main drug for treatment is methylphenidate. We identified the prevalence of ADDH by determining the use of this drug in our environment.
There are few data on the prevalence of ADDH in the literature, but our data are in line with the ranges cited in various articles.